Evaluation of recent intranasal drug delivery systems to the central nervous system

TP Crowe, WH Hsu - Pharmaceutics, 2022 - mdpi.com
Neurological diseases continue to increase in prevalence worldwide. Combined with the
lack of modifiable risk factors or strongly efficacious therapies, these disorders pose a …

Nanoparticle-guided brain drug delivery: Expanding the therapeutic approach to neurodegenerative diseases

C Riccardi, F Napolitano, D Montesarchio, S Sampaolo… - Pharmaceutics, 2021 - mdpi.com
Neurodegenerative diseases (NDs) represent a heterogeneous group of aging-related
disorders featured by progressive impairment of motor and/or cognitive functions, often …

Advances and future perspectives of intranasal drug delivery: A scientometric review

D Xu, XJ Song, X Chen, JW Wang, YL Cui - Journal of Controlled Release, 2024 - Elsevier
Intranasal drug delivery is as a noninvasive and efficient approach extensively utilized for
treating the local, central nervous system, and systemic diseases. Despite numerous …

Lipid-based nanoparticles via nose-to-brain delivery: A mini review

Y Xinchen, T Jing, G Jiaoqiong - Frontiers in Cell and Developmental …, 2023 - frontiersin.org
Central nervous system disorders significantly affect the lives and health of millions of
people worldwide. Despite many therapeutic drugs are available that could potentially target …

Recent advances in nanotechnology for Intra-nasal drug delivery and clinical applications

G Rai, P Gauba, S Dang - Journal of Drug Delivery Science and …, 2023 - Elsevier
Nanotechnology has proved its tremendous worth in the field of drug delivery and targeting.
Nano formulations have improved the safety and efficacy of various conventional drugs …

[HTML][HTML] Targeting glioblastoma through nano-and micro-particle-mediated immune modulation

E Poot, A Maguregui, VG Brunton, D Sieger… - Bioorganic & Medicinal …, 2022 - Elsevier
Glioblastoma Multiforme (GBM) is a multifaceted and complex disease, which has
experienced no changes in treatment for nearly two decades and has a 5-year survival rate …

Design, Characterization, and Application of a pH-Triggered In Situ Gel for Ocular Delivery of Vinpocetine

Q Ma, R Luo, H Zhang, M Dai, L Bai, Q Fei, F Lei… - AAPS …, 2020 - Springer
We developed a pH-triggered in situ gel (ISG) for ocular delivery of vinpocetine to achieve
systemic absorption and a brain-targeting effect in rats. Carbopol acted as a gelling agent …

Targeting neuroimmune interactions in diabetic neuropathy with nanomedicine

M Balogh, JM Janjic, AJ Shepherd - Antioxidants & redox signaling, 2022 - liebertpub.com
Significance: Diabetes is a major source of neuropathy and neuropathic pain that is set to
continue growing in prevalence. Diabetic peripheral neuropathy (DPN) and pain associated …

[HTML][HTML] Nanoformulation innovations: Revolutionizing precision in migraine therapy

MG Narimani, F Kalalinia, S Marouzi… - Iranian Journal of …, 2025 - pmc.ncbi.nlm.nih.gov
Objective (s): Migraine, a serious neurological disease that affects millions of people
worldwide, is one of the most considerable burdens on the healthcare system and has …

Importance of nano-carriers, surfactant system, and their loading mechanism to improve the absorption and bio-availability of drugs: a review

NA Azeez, K Venkateshwaran… - Advances in Natural …, 2024 - iopscience.iop.org
Improving the apparent solubility of poorly soluble therapeutic molecules with poor
absorption into the circulatory system is a significant research question in drug discovery …